MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-09-0030962
Nutrigene Biosciences Private Limited - life sciences in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹3.24 Cr
▲ 685% YoY
Net loss · FY 2024
₹1.65 Cr
Net margin -50.8%
EBITDA · FY 2024
-₹1.6 Cr
EBITDA margin -49.3%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹4.66 Cr
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
5
As per MCA filings
Key managerial staff
1
CEO, CFO, company secretary
About Nutrigene Biosciences Private Limited
Data last updated:
Nutrigene Biosciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 20 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2020PTC145055. Its GSTIN is 36AAUCA2490H1ZB (Telangana).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.66 Cr. It was formerly known as Ikigai Bioworks Private Limited and Afya Nutrition and Biosciences Private Limited. It is led by directors including Trushit Pramodray Mehta and Tejash Vijay Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No 201 Teja Block My Home Navadeepa Madhapur, Hyderabad, Telangana, India – 500081.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.24 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹1.65 Cr (net margin -50.8%) and EBITDA of -₹1.6 Cr (EBITDA margin -49.3%).
The company has 3 deals on record (1 rights issue, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹2.65 Cr; the latest was in September 2023. Its 3 peer companies in the Biotechnology industry (Biosciences, Biotechnology), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 smaller; the largest is S T S Biotech Private Limited with revenue of ₹3.23 Cr.
Nutrigene Biosciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0030962). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nutrigene.bio.
Company details
CIN U24290TG2020PTC145055
Registration Number 145055
Incorporation Date 20 October 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-09-0030962
Name history
Nutrigene Biosciences has undergone 2 name changes throughout its history. The company was previously known as Ikigai Bioworks Private Limited, and Afya Nutrition And Biosciences Private Limited. The current legal name is Nutrigene Biosciences Private Limited.
| Company Name | Status |
|---|---|
| Nutrigene Biosciences Private Limited | Current |
| Ikigai Bioworks Private Limited | Previous |
| Afya Nutrition And Biosciences Private Limited | Previous |
Key People
Keerthi Vardhan Vadlamani Ceo Trushit Pramodray Mehta Director Tejash Vijay Shah Director Recognitions & Rankings of Nutrigene Biosciences
Contact details
Nutrigene Biosciences Private Limited's registered office is in Hyderabad, Telangana. Its website is nutrigene.bio. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressFlat No 201 Teja Block My Home Navadeepa Madhapur, Hyderabad, Telangana, India – 500081
- IndustryLife Sciences, Biotechnology
To see the full contact details of Nutrigene Biosciences Private Limited, buy the company report.
Comprehensive company report
Nutrigene Biosciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Nutrigene Biosciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Nutrigene Biosciences Private Limited, buy the company report.
Financials of Nutrigene Biosciences Private Limited
FY 2025 filings availableNutrigene Biosciences Private Limited reported revenue of ₹3.24 Cr (up 685% YoY) for FY 2024.
Revenue · FY 2024
₹3.24 Cr ▲ 685%
Net loss · FY 2024
₹1.65 Cr margin -50.8%
EBITDA · FY 2024
-₹1.6 Cr margin -49.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 685%
EBITDA CAGR growth
1 year
▼ 105%
3 years · compounded
▼ 648%
Revenue rose 685% in the latest year. EBITDA fell 105% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹1.6 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹1.65 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -49.3% | |||
| Net Profit Margin | -50.8% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Nutrigene Biosciences Private Limited, buy the company report.
Board of directors and KMP of Nutrigene Biosciences Private Limited
Nutrigene Biosciences Private Limited currently reports 4 directors and 1 key managerial person. 8 former directors have served the organization.
Current Directors and KMP
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Trushit Pramodray Mehta | Director | 21 Aug 2023 | 3 Years 2 Months | Current |
| Tejash Vijay Shah Also directs: Majorelle LLP, BDR Lifesciences Private Limited, BDR Pharmaceuticals International Private Limited and 1 more | Director | 21 Aug 2023 | 3 Years 2 Months | Current |
| Keerthi Vardhan Vadlamani | Ceo | 01 Oct 2023 | 3 Years 1 Months | Current |
| Raheel Dharmesh Shah Also directs: BDR Lifesciences Private Limited, BDR Pharmaceuticals International Private Limited, Magnum Chemi-Gran Private Limited and 3 more | Director | 21 Aug 2023 | 3 Years 2 Months | Current |
| Katta Vijay Kumar | Director | 21 Aug 2023 | 3 Years 2 Months | Current |
Peer comparison
Nutrigene Biosciences Private Limited is compared with the 3 companies closest to it by revenue in the Biotechnology industry (Biosciences, Biotechnology), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nutrigene Biosciences Private Limitedthis company | ₹3.24 Cr (FY 2024) | -₹1.65 Cr | -50.8% | 685.0% | Hyderabad, Telangana, India | |
| S T S Biotech Private Limited | ₹3.23 Cr (FY 2024) | 99.0% | Mysore, Karnataka, India | |||
| Loka Biosciences Private Limited | ₹3.22 Cr (FY 2025) | -32.0% | Hyderabad, Telangana, India | |||
| Human Biosciences India Limited | ₹3.21 Cr (FY 2025) | -30.0% | Delhi, India |
To see the full peer comparison of Nutrigene Biosciences Private Limited, buy the company report.
Auditor
Nutrigene Biosciences Private Limited is audited by G P M & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G P M & ASSOCIATES | FY 2023 | 015343S |
Shareholding
The shareholding of Nutrigene Biosciences Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Nutrigene Biosciences Private Limited, buy the company report.
Deals & funding
Nutrigene Biosciences Private Limited has 3 deals on record (1 rights issue, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹2.65 Cr; the latest was in September 2023.
Total deals
3
Rights issue
1
Funding round
1
Secondary share transfer
1
Disclosed funding
₹2.65 Cr
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2023 | Funding round | ₹2.65 Cr | Investors: BDR Pharmaceuticals International Private Limited |
| Jun 2023 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Dec 2021 | Rights issue | ₹2 Cr | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Nutrigene Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nutrigene Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Nutrigene Biosciences Private Limited has 1 active EPFO establishment as of Mar 27, 2024.
Active EPFO establishments
1
GST
Nutrigene Biosciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAUCA2490H1ZB | Telangana | Active | 08 Jul 2021 |
To see the full GST registrations and return filing status of Nutrigene Biosciences Private Limited, buy the company report.
Recent activity
Nutrigene Biosciences Private Limited has 13 board changes on record since 2021: 5 appointments and 8 cessations. The latest: Keerthi Vardhan Vadlamani was appointed as CEO on 01 Oct 2023.
AGM
Nutrigene Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nutrigene Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Keerthi Vardhan Vadlamani was appointed as CEO.
Ceased
Keerthi Vardhan Vadlamani ceased to be Director.
Ceased
Sanjay Chaturvedi ceased to be Director.
Ceased
Katta Vijay Kumar ceased to be Additional Director.
Ceased
Raheel Dharmesh Shah ceased to be Additional Director.
Ceased
Savitri Vadlamani ceased to be Additional Director.
Ceased
Tejash Vijay Shah ceased to be Additional Director.
Ceased
Trushit Pramodray Mehta ceased to be Additional Director.
Appointed
Katta Vijay Kumar was appointed as Director.
Appointed
Raheel Dharmesh Shah was appointed as Director.
4 earlier events are in the company report.
Frequently asked questions
Nutrigene Biosciences is an active private limited company based in Hyderabad, Telangana, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 20 October 2020 (6+ years old) and is registered under CIN U24290TG2020PTC145055.
Nutrigene Biosciences has 5 current directors and KMP:
- Trushit Pramodray Mehta - Director
- Tejash Vijay Shah - Director
- Raheel Dharmesh Shah - Director
- Katta Vijay Kumar - Director
- Keerthi Vardhan Vadlamani - Ceo
The latest financial statements of Nutrigene Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Nutrigene Biosciences is 36AAUCA2490H1ZB, registered in Telangana.
The CIN (Corporate Identification Number) of Nutrigene Biosciences is U24290TG2020PTC145055. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nutrigene Biosciences was incorporated on 20 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
Nutrigene Biosciences has 3 deals on record (1 rights issue, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹2.65 Cr; the latest was in September 2023.
The peers of Nutrigene Biosciences by revenue are S T S Biotech Private Limited, Loka Biosciences Private Limited, Human Biosciences India Limited, all in the Biotechnology industry (Biosciences, Biotechnology), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Keerthi Vardhan Vadlamani was appointed as CEO on 01 Oct 2023. Keerthi Vardhan Vadlamani ceased to be Director on 30 Sep 2023. Sanjay Chaturvedi ceased to be Director on 30 Sep 2023. Nutrigene Biosciences has 13 board changes on record in total.
Yes, Nutrigene Biosciences is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-09-0030962).
Nutrigene Biosciences can be reached through the website nutrigene.bio. Its registered office is in Hyderabad, Telangana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages